ThaiPR.NET https://www.thaipr.net/location/miami-and-florence-italy-and-naarden-netherlands Press Release Distribution Center of Thailand Thu, 30 Apr 2026 16:57:21 +0700 hourly 1 https://wordpress.org/?v=6.1.1 <![CDATA[NewAmsterdam Pharma and the Menarini Group Sign Licensing Deal to Commercialize Obicetrapib in Europe]]> https://www.thaipr.net/en/health_en/3208045 Wed, 29 Jun 2022 17:16:00 +0700 health_en https://www.thaipr.net/en/health_en/3208045 – Combines NewAmsterdam’s lead clinical program obicetrapib with Menarini’s deep cardiovascular disease and regional expertise – Total deal value of over €1 billion; including €142.5 million upfront payment and committed R&D funding plus potential milestones and double-digit royalties on net product sales in Europe – Obicetrapib is a next-generation oral, low-dose and once-daily CETP inhibitor for […]

The post NewAmsterdam Pharma and the Menarini Group Sign Licensing Deal to Commercialize Obicetrapib in Europe appeared first on ThaiPR.NET.

]]>